International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines

CN Dodd; SA Romio; S Black; C Vellozzi; N Andrews; M Sturkenboom; P Zuber; W Hua; J Bonhoeffer; J Buttery; N Crawford; G Deceuninck; C de Vries; P De Wals; MVG Gimeno; H Heijbel; H Hughes; K Hur; A Hviid; J Kelman; T Kilpi; SK Chuang; K Macartney; M Rett; VR Lopez-Callada; D Salmon; FG Sanchez; N Sanz; B Silverman; J Storsaeter; U Thirugnanam; N van der Maas; K Yih; T Zhang; H Izurieta; A Addis; A Akhtar; J Cope; R Davis; P Gargiullo; X Kurz; B Law; I Sahinovic; J Tokars; P Serrano; A Cheng; N Andrews; P Charles; H Clothier; B Day; T Day; P Gates; R MacDonnell; L Roberts; VT Rodriguez-Casero; T Wijeratne; L Kiers; C Blyth; R Booy; E Elliott; M Gold; H Marshall; P McIntyre; P Richmond; J Royle; N Wood; Y Zurynski; G Calvo; M Campins; N Corominas; F Torres; J Valls; A Vilella; D Dutra; A Eick-Cost; HM Jackson; P Garman; Z Hu; M Rigo; J Badoo; D Cho; LL Polakowski; SK Sandhu; G Sun; HSS Chan; KY Chan; R Cheung; YF Cheung; S Cherk; SK Chuang; JWM Fok; BH Fung; KF Ko; KW Lau; KK Lau; P Li; HT Liu; SH Liu; T Mok; J So

Journal article

International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines

CN Dodd, SA Romio, S Black, C Vellozzi, N Andrews, M Sturkenboom, P Zuber, W Hua, J Bonhoeffer, J Buttery, N Crawford, G Deceuninck, C de Vries, P De Wals, MVG Gimeno, H Heijbel, H Hughes, K Hur, A Hviid, J Kelman Show all

Vaccine | Published : 2013

DOI: 10.1016/j.vaccine.2013.06.032

Abstract

Background: The global spread of the 2009 novel pandemic influenza A (H1N1) virus led to the accelerated production and distribution of monovalent 2009 Influenza A (H1N1) vaccines (pH1N1). This pandemic provided the opportunity to evaluate the risk of Guillain-Barré syndrome (GBS), which has been an influenza vaccine safety concern since the swine flu pandemic of 1976, using a common protocol among high and middle-income countries. The primary objective of this project was to demonstrate the feasibility and utility of global collaboration in the assessment of vaccine safety, including countries both with and without an established infrastructure for vaccine active safety surveillance. A seco..

View full abstract

University of Melbourne Researchers

Jim Buttery Author

Nigel Crawford Author

Pat Charles Author Infectious Diseases

Hazel Clothier Author

Grants

Funding Acknowledgements

Minimal funding was provided by the World Health Organization and by the US Food and Drug Administration for creation and maintenance of an online workspace as well as travel for group statisticians to conduct data analysis. No funding was provided to investigators for their participation.